News-Medical.Net on MSN

GeneSight test-guided treatment leads to faster remission and response in patients with depression

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis ...
Medscape

When Obesity and Depression Coexist — How to Manage Both

Shared biological, psychological, and social pathways put patients at risk for both, whether obesity or depression occurs ...

New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner

Faster initial remission and response, persistent benefit over six monthsSALT LAKE CITY, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic ...
The Week

Are women genetically more vulnerable to depression than men? New study reveals this

A recent study published in Nature Communications may have an answer. It found that women have a higher genetic risk of ...
MedPage Today on MSN

Trial Questions Ketamine Use for Patients Hospitalized With Depression

A 2022 study showed that 28.3% of patients receiving ketamine had a billing diagnosis of depression. McLoughlin's group ...
Tyla

Warning signs you could be sliding into ‘dysthymia’

Also known as 'persistent depressive disorder' the condition is described as a milder but more chronic form of depression.
Psychology Today

Genetic Marker Identifies Responders to New Antidepressant

A new medication for treatment-resistant depression may help a subset of people who carry a specific genetic marker.

How I Worked Through My Depression Treatment and Resulting Sexual Dysfunction

One man living with major depressive disorder shares how working with his psychiatrist led him to understand his treatment-emergent sexual dysfunction.

Antidepressants improve core depressive symptoms early on, analysis finds

One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety ...